EXANE DERIVATIVES - ENVISION HEALTHCARE CORP ownership

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of ENVISION HEALTHCARE CORP
ValueSharesWeighting
Q3 2018$731,000
-99.7%
16
-99.7%
0.00%
-100.0%
Q2 2018$217,998,000
-63.0%
4,945
-68.0%
0.04%
-69.5%
Q1 2018$589,349,000
-34.3%
15,446
-40.5%
0.12%
-23.4%
Q4 2017$896,950,000
+88.8%
25,966
+145.6%
0.15%
+73.0%
Q3 2017$475,184,00010,5740.09%
Other shareholders
ENVISION HEALTHCARE CORP shareholders Q3 2023
NameSharesValueWeighting ↓
BANBURY PARTNERS LLC 621,050$38,083,00010.74%
Stonerise Capital Management, LLC 75,000$4,599,00010.60%
12th Street Asset Management Company, LLC 384,362$23,569,0006.83%
BLOOM TREE PARTNERS, LLC 1,043,710$64,000,0006.21%
Claar Advisors LLC 277,777$17,033,0005.94%
BRIDGER MANAGEMENT, LLC 1,419,083$87,018,0004.96%
SouthernSun Asset Management 3,127,024$191,749,0004.90%
ShearLink Capital, LLC 187,892$11,522,0004.58%
CLEARFIELD CAPITAL MANAGEMENT LP 256,927$15,755,0003.44%
WELCH CAPITAL PARTNERS LLC/NY 164,479$10,086,0003.33%
View complete list of ENVISION HEALTHCARE CORP shareholders